Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T16:23:01.914Z.
Calculation as of: 2026-10-06T16:23:01.914Z.
Quote observation: 2026-10-06T16:20:47.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 7de7752a9f7c92cf302168b3adc2b8952dbd3ee015c15fa7e623ade4200d4f53
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Jade Biosciences, Inc.
Market Cap
$823.43M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$838.62M
Free Cash Flow Yield
N/A
TTM Avg
1.33%
3Y Avg
1.33%
5Y Avg
1.33%
Market Cap
$809.02M
Free Cash Flow Yield
N/A
TTM Avg
24.40%
3Y Avg
22.30%
5Y Avg
22.30%
Market Cap
$850.77M
Free Cash Flow Yield
N/A
TTM Avg
2.73%
3Y Avg
5.44%
5Y Avg
9.24%
Market Cap
$805.59M
Free Cash Flow Yield
10.86%
TTM Avg
10.11%
3Y Avg
10.17%
5Y Avg
7.95%
Market Cap
$846.87M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$797.70M
Free Cash Flow Yield
N/A
TTM Avg
0.32%
3Y Avg
2.22%
5Y Avg
3.37%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jade Biosciences, Inc. (JBIO) | $823.43M | N/A | N/A | N/A | N/A |
| Pacific Biosciences of California, Inc. (PACB)vs › | $838.62M | N/A | 1.33% | 1.33% | 1.33% |
| Ardelyx, Inc. (ARDX)vs › | $809.02M | N/A | 24.40% | 22.30% | 22.30% |
| QuidelOrtho Corporation (QDEL)vs › | $850.77M | N/A | 2.73% | 5.44% | 9.24% |
| InMode Ltd. (INMD)vs › | $805.59M | 10.86% | 10.11% | 10.17% | 7.95% |
| Beta Bionics, Inc. (BBNX)vs › | $841.98M | N/A | N/A | N/A | N/A |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $846.87M | N/A | N/A | N/A | N/A |
| Alumis Inc. (ALMS)vs › | $848.46M | N/A | N/A | N/A | N/A |
| Gyre Therapeutics, Inc. (GYRE)vs › | $797.70M | N/A | 0.32% | 2.22% | 3.37% |
| Apnimed, Inc. (APMD)vs › | $790.49M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
